Attention on marijuana stocks has begun to increase since uncertainty last year during midterm elections spawned a consolidation period just before the close of the year.

As the new outlook for 2015 became more positive for companies in the sector, the January effect has had its way with many of these stocks and several continue to see new highs.   With major investment coming into the industry, there’s no doubt that this will continue to be a topic of interest in the coming year.  Just recently Paypal co-founder Peter Thiel invested in the marijuana industry through a minority stake in Privateer Holdings (through his own fund, The Founders Fund).  Seemingly the marijuana industry’s biggest investor thus far has created a domino effect within the public markets, giving more confidence to otherwise prudent investors.

Oxis Inernational Inc (OTC:OXIS) recently announced that it had executed a worldwide exclusive patent licensing for certain assets for the treatment of Multiple Myeloma and initiated a consulting agreement with University of Pittsburgh’s Professor, Dr. Xiang-Qun(Sean)Xie.  Dr. Xie is one of the foremost cannabinoid research scientists in the world and boasts a track record of success that’s a mile long.  The license agreement provides Oxis Biotech, Inc an exclusive worldwide license to develop and commercialize therapies for the treatment of Multiple Myeloma.

Over the last 10 days, OXIS has managed to reach two major and very important milestones, which may have been cause of so much market attention building around this company.  They went from caveat emptor status on OTCMarkets to a Current PinkSheet after getting all of the filings up to date.  Furthermore Oxis entered into this recent licensing agreement.  Since mid-December not only has the stock been on a very consistent upward trend but it has also seen highs of nearly $0.04; coming up from lows of just over a penny.

Advanced Cannabis Solutions (OTC: CANN) is a service provider to businesses in the cannabis industry.  Recently the company announced that it has signed a Master Services Agreement with New York based Spector Group, one of the nation’s leading architecture, interior design and master planning firms, for the build out of its multi-tenant office building in Denver, to be known as “The Greenhouse.” Robert Frichtel, Chief Executive Officer of ACS, commented, “We are very glad to have Spector Group come on board with this project. As an established and highly experienced firm, we are confident that Spector will bring our vision of The Greenhouse to life quickly and with a minimum of difficulty.”

Over the last 2 weeks, Advanced Cannabis has been on a warpath for big gains.  The stock opened the year at $1 and has since jumped more than 400% to highs on Tuesday of $4.50. Similar to Oxis just a few weeks ago, Advanced Cannabis is reporting a Caveat Emptor status on OTC Markets.

United Cannabis Corporation (CNAB) has also come across the radar of many marijuana stock investors.  This month the company announced that it has signed a consulting and licensing agreement with FoxBarry Farms, LLC, whereby FoxBarry will be the exclusive licensee and distributor of United Cannabis branded medical marijuana products in the State of California.

FoxBarry has earmarked $30 million to fund all phases of the California state-wide program. The Company will receive $200,000 in prepaid royalties for exclusive licensing rights in the State of California and the first location will be located in Northern California; operations are expected to begin in the next 30-45 days.  During the matter of a few days, United Cannabis’ stock price has been on a bull run.  Since opening the year around $0.70, this stock has seen an increase in volume and a jump in price by roughly 91% in the matter of just a few weeks.  Sentiment remains high (no pun intended) across the marijuana sector and these companies have garnered more interest from traders and investors alike.

About is the leading web destination for all things cannabis. Investors can find marijuana related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. DAMJ VENTURES LLC which owns, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release.

DAMJ VENTURES LLC, which owns, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. DAMJ VENTURES LLC which owns, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.

Contact Information:


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Marijuana Stocks Newsletter – August 22, 2019

FORBES Scoop: Aphria (APHA) Signs New Cannabis Delivery Partnership In Canada NYSE-traded…